Analyst upgrades: AAPL, UBS, AZN and KLAC

Published: April 7, 2008, 7:08 am

Tags: aapl, aauk, analyst, anglo american, angloamerican, apple, astrazeneca, azn, comscore, inthenews, kla tencor, klac, scor, ubs, upgrade

Filed under: Analyst reports, Analyst upgrades and downgrades, Apple Inc (AAPL), Anglo Amer ADR (AAUK)MOST NOTEWORTHY: Apple, AstraZeneca and KLA-Tencor were today's noteworthy upgrades: Thomas Weisel upgraded Apple (NASDAQ: AAPL) to Overweight from Market Weight, citing a re-set in FY08 expectations and expected growth from Mac market share gains, accelerating iPhone revenue growth and increased iPhone ASPs. WestLB upgraded shares of AstraZeneca (NYSE: AZN) to Add from Hold as they believe the company's growth in core franchises are being overlooked. Citigroup upgraded KLA-Tencor (NASDAQ: KLAC) to Buy from Hold , as they believe several near-term catalysts are likely to develop against an increasingly favorable cyclical backdrop. They think KLAC's near-term business is better than most think and maintain a $56 target on the stock. OTHER UPGRADES: Goldman upgraded Anglo American (NASDAQ: AAUK) to Buy from Neutral and added shares to the Conviction Buy List.

[ Full article ]

Blog link

Rating: 0

Comments